FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 99 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q1 2022. The put-call ratio across all filers is 6.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,001,000 | +234.2% | 701,849 | +15.4% | 0.00% | +100.0% |
| Q2 2022 | $4,189,000 | -20.2% | 608,088 | +7.8% | 0.00% | 0.0% |
| Q1 2022 | $5,248,000 | -33.4% | 564,312 | +1.9% | 0.00% | 0.0% |
| Q4 2021 | $7,874,000 | -31.0% | 553,776 | +12.5% | 0.00% | -50.0% |
| Q3 2021 | $11,418,000 | +2.7% | 492,369 | +10.2% | 0.00% | 0.0% |
| Q2 2021 | $11,117,000 | -8.4% | 446,647 | +3.1% | 0.00% | 0.0% |
| Q1 2021 | $12,140,000 | +17.9% | 433,287 | +46.9% | 0.00% | 0.0% |
| Q4 2020 | $10,295,000 | -20.5% | 295,004 | +13.5% | 0.00% | -33.3% |
| Q3 2020 | $12,950,000 | +1246.2% | 259,839 | +1155.6% | 0.00% | – |
| Q2 2020 | $962,000 | – | 20,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,526 | $36,305,000 | 5.70% |
| Cormorant Asset Management, LP | 4,720,495 | $109,468,000 | 4.45% |
| Logos Global Management LP | 2,115,000 | $49,047,000 | 3.54% |
| RA Capital Management | 9,011,651 | $208,980,000 | 2.90% |
| Opaleye Management Inc. | 182,950 | $4,243,000 | 0.79% |
| Artal Group S.A. | 1,000,000 | $23,190,000 | 0.52% |
| HighVista Strategies LLC | 26,711 | $619,000 | 0.41% |
| Integral Health Asset Management, LLC | 60,000 | $1,391,000 | 0.40% |
| HHLR ADVISORS, LTD. | 1,100,000 | $25,509,000 | 0.33% |
| Baker Brothers Advisors | 2,024,876 | $46,957,000 | 0.21% |